UK markets closed

Biodesix, Inc. (BDSX)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
7.88+0.37 (+4.93%)
As of 1:17PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close7.51
Open7.58
Bid7.79 x 1200
Ask7.88 x 4000
Day's range7.54 - 7.94
52-week range6.52 - 31.99
Volume17,036
Avg. volume116,826
Market cap212.528M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-1.74
Earnings date08 Dec 2021 - 13 Dec 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est23.33
  • Business Wire

    Biodesix Announces New Data on Nodify Lung® Nodule Risk Assessment Testing at the CHEST 2021 Annual Meeting

    BOULDER, Colo., October 13, 2021--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company, today announced that multiple data presentations will occur at the 2021 annual CHEST virtual conference. Presentations will include newly emerging data from the post-market, prospective, real-world ORACLE study (An Observational Registry Study to Evaluate the Performance of the Nodify XL2® Test - ORACLE [NCT03766958]), demonstrating that incorporation of this blood-based test in t

  • Business Wire

    Biodesix Announces Abstracts Presented During the IASLC 2021 World Conference on Lung Cancer

    BOULDER, Colo., September 16, 2021--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that two abstracts highlighting proteomic and genomic data based on their diagnostic tests were presented at the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer (WCLC).

  • Business Wire

    Biodesix to Present at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference

    BOULDER, Colo., September 02, 2021--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will present in a fireside chat the Morgan Stanley Virtual 19th Annual Global Healthcare Conference being held virtually September 9-10 and September 13-15, 2021.